Company intelligence / Profile preview
ThromBio
Sydney, New South Wales (NSW), Australiathrombio.com.au ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
TBO‑309 has shown promising preclinical results improving blood flow to the brain without causing excessive bleeding—a major safety advantage over existing antiplatelet drugs like aspirin. Phase II trials are underway in Australia involving about 80 patients across six hospitals. The drug targets PI3K-beta and aims to reduce brain injury after ischemic stroke with an unprecedented safety profile[2][3][5].
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Novel anti-thrombotic drugs, specifically peptides and small molecules such as TBO-309 which is a new chemical entity administered intravenously.Peptide-based therapeutics derived from natural anti-clotting agents.
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Heart Research Institute (HRI), Sydney – collaborative research partner providing scientific expertise[3].University of Sydney – academic collaboration licensing novel peptides for stroke therapy development[5].
Beyond the preview
Go deeper on ThromBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ThromBio.